ENVALITH
ミアヘルサホールディングス株式会社 logo

Miahelsa Holdings Corporation

7129Standard MarketRetail Trade

ミアヘルサホールディングス株式会社 logo
Miahelsa Holdings Corporation7129
Reference Indicators

Market Cap

32¥100M

P/E (Forecast)

9.0x

P/B

0.8x

Dividend Yield (Forecast)

2.59%

ROE

5.2%

EV/EBITDA

3.1x
Financial Summary
Unit: ¥M
Item
2022Mar 2022
2023Mar 2023
2024Mar 2024
2025Mar 2025
2026Mar 2026
Net Sales
19,51022,24922,72223,82524,850
Cost of Sales
17,61220,23720,55821,43322,181
Gross Profit
1,8972,0112,1642,3912,669
SG&A Expenses
1,7111,8201,7691,7501,845
Operating Income
186191395641824
Non-operating Income
10210399104112
Non-operating Expenses
98125120101109
Ordinary Income
189169374644827
Extraordinary Income
4793654926864
Extraordinary Losses
135186359426455
Pre-tax Income
53334763486437
Income Taxes
24213858186236
Net Income
2912095299200
EBITDA
7108341,0491,2691,412
Gross Margin
9.7%9.0%9.5%10.0%10.7%
Operating Margin
1.0%0.9%1.7%2.7%3.3%
ROA
2.1%1.5%0.0%2.3%1.3%
ROE
9.4%6.3%0.2%8.4%5.2%
Segment Performance
Unit: ¥M
2026
SegmentNet SalesOperating IncomeOperating Margin
医薬事業9,9475025.0%
子育て支援事業10,2941,25712.2%
介護事業3,538551.6%
その他1,069373.5%